TY - JOUR
T1 - Circulating IL-15 exists as heterodimeric complex with soluble IL-15Rα in human and mouse serum
AU - Bergamaschi, Cristina
AU - Bear, Jenifer
AU - Rosati, Margherita
AU - Beach, Rachel Kelly
AU - Alicea, Candido
AU - Sowder, Raymond
AU - Chertova, Elena
AU - Rosenberg, Steven A.
AU - Felber, Barbara K.
AU - Pavlakis, George N.
PY - 2012/7/5
Y1 - 2012/7/5
N2 - IL-15 is an important cytokine for the function of the immune system, but the form(s) of IL-15 produced in the human body are not fully characterized. Coexpression of the single-chain IL-15 and the IL-15 receptor alpha (IL-15Rα) in the same cell allows for efficient production, surface display, and eventual cleavage and secretion of the bioactive IL-15/IL-15Rα heterodimer in vivo, whereas the single-chain IL-15 is poorly secreted and unstable. This observation led to the hypothesis that IL-15 is produced and secreted only as a heterodimer with IL-15Rα. We purified human IL-15/IL-15Rα complexes from overproducing human cell lines and developed an ELISA specifically measuring the heterodimeric form of IL-15. Analysis of sera from melanoma patients after lymphodepletion revealed the presence of circulating IL-15/IL-15Rα complexes in amounts similar to the total IL-15 quantified by a commercial IL-15 ELISA that detects both the single-chain and the heterodimeric forms of the cytokine. Therefore, in lymphodepleted cancer patients, the serum IL-15 is exclusively present in its heterodimeric form. Analysis of the form of IL-15 present in either normal or lymphodepleted mice agrees with the human data. These results have important implications for development of assays and materials for clinical applications of IL-15.
AB - IL-15 is an important cytokine for the function of the immune system, but the form(s) of IL-15 produced in the human body are not fully characterized. Coexpression of the single-chain IL-15 and the IL-15 receptor alpha (IL-15Rα) in the same cell allows for efficient production, surface display, and eventual cleavage and secretion of the bioactive IL-15/IL-15Rα heterodimer in vivo, whereas the single-chain IL-15 is poorly secreted and unstable. This observation led to the hypothesis that IL-15 is produced and secreted only as a heterodimer with IL-15Rα. We purified human IL-15/IL-15Rα complexes from overproducing human cell lines and developed an ELISA specifically measuring the heterodimeric form of IL-15. Analysis of sera from melanoma patients after lymphodepletion revealed the presence of circulating IL-15/IL-15Rα complexes in amounts similar to the total IL-15 quantified by a commercial IL-15 ELISA that detects both the single-chain and the heterodimeric forms of the cytokine. Therefore, in lymphodepleted cancer patients, the serum IL-15 is exclusively present in its heterodimeric form. Analysis of the form of IL-15 present in either normal or lymphodepleted mice agrees with the human data. These results have important implications for development of assays and materials for clinical applications of IL-15.
UR - http://www.scopus.com/inward/record.url?scp=84863562572&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84863562572&partnerID=8YFLogxK
U2 - 10.1182/blood-2011-10-384362
DO - 10.1182/blood-2011-10-384362
M3 - Article
C2 - 22496150
AN - SCOPUS:84863562572
SN - 0006-4971
VL - 120
SP - e1-e8
JO - Blood
JF - Blood
IS - 1
ER -